Technology and health care in an era of limits
Author(s)
Bibliographic Information
Technology and health care in an era of limits
(Medical innovation at the crossroads, v. 3)
National Academy Press, 1992
Available at / 8 libraries
-
No Libraries matched.
- Remove all filters.
Note
Papers presented at the third Institute of Medicine workshop "The Changing Health Care Economy," held April 18-19, 1991, supported by the Howard Hughes Medical Institute, Pfizer, Inc., and the Health Industry Manufacturers Association
Includes bibliographical references and index
Description and Table of Contents
Description
The U.S. health care system is in a state of flux, and changes currently under way seem capable of exerting sizable effects on medical innovation.
This volume explores how the rapid transition to managed care might affect the rate and direction of medical innovation. The experience with technological change in medicine in other nations whose health care systems have "single-payer" characteristics is thoroughly examined.
Technology and Health Care in an Era of Limits examines how financing and care delivery strategies affect the decisions made by hospital administrators and physicians to adopt medical technologies. It also considers the patient's stake in the changing health care economy and the need for a stronger independent contribution of patients to the choice of technology used in their care.
Finally, the volume explores the impact of changes in the demand for medical technology in pharmaceutical, medical device, and surgical procedure innovation.
Table of Contents
FRONT MATTER
PART I: SETTING THE STAGE
PART II: MANAGING CARE IN THE UNITED STATES
PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
PART IV: IMPLICATIONS FOR PROVIDERS
PART V: IMPLICATIONS FOR PATIENTS
PART VI: IMPLICATIONS FOR INNOVATORS
PART VII: CONCLUDING OBSERVATIONS
APPENDIXES
INDEX
Table of Contents
- 1 FRONT MATTER
- 2 PART I: SETTING THE STAGE
- 3 PART II: MANAGING CARE IN THE UNITED STATES
- 4 PART III: MANAGING CARE IN THE UNITED KINGDOM AND CANADA
- 5 PART IV: IMPLICATIONS FOR PROVIDERS
- 6 PART V: IMPLICATIONS FOR PATIENTS
- 7 PART VI: IMPLICATIONS FOR INNOVATORS
- 8 PART VII: CONCLUDING OBSERVATIONS
- 9 APPENDIXES
- 10 INDEX
by "Nielsen BookData"